Abstract
Four color processed whole body bone scintigraphy with 99mTc-methylene diphosphonate was performed in six patients on maintenance hemodialysis, and the results of semiquantitative colorimetric analysis were compared with those of a normal group. The difference between the two (control and patient group) was statistically significant (P<0.01). Furthermore, the effect of 1α-hydroxyvitamin D3 treatment on renal osteodystrophy was evaluated by this method. The results indicated that this method provides a useful method for assessing the response of renal osteodystrophy to treatment. Two representative cases of renal osteodystrophy are presented to illustrate the usefulness of this approach to semiquantitative whole body bone scanning.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Büll U, Schuster H, Pfeifer JP, Tongendorff J, Niendorf HP (1977) Bone-to-bone, joint-to-bone and joint-to-joint ratios in normal and diseased skeletal states using region-of-interest technique and bone-seeking radiopharmaceuticals. J Nucl Med 16:104–112
Citrin DL, Bessent RG, Tuhoy JB, Grieg WR, Blumgart LH (1974) Quantitative bone scanning: a method for assessing response of bone metastases to treatment. Lancet 1:1132–1133
Citrin DL, Bessent RG, McGinlay E, Gordon D (1975) Dynamic studies with 99mTc-HEDP in normal subjects and in patients with bone tumors. J Nucl Med 16:886–890
Cox PH, Belfer AJ, Van Dongen DJ, Perberger R, Treurniet RE (1977) The clinical reliability of 99mTc-polyphosphate skeletal scintigraphy in the early detection of bone metastases. Eur J Nucl Med 2:43–46
De Graaf P, Schicht IM, Pauwels EKJ, te Velde J, de Graeff J (1978) Bone scintigraphy in renal osteodystrophy. J Nucl Med 19:1289–1296
De Graaf P, te Velde J, Pauwels EKJ, Schicht IM, Kleiverda K, de Graeff J (1982) Increased bone radiotracer uptake in renal osteodystrophy. Clinical evidence of hypoparathyroidism as the major cause. Eur J Nucl Med 7:152–154
De Graaf P, Schicht IM, te Velde J, Pauwels EKJ, Kleiverda K, de Graeff (1983) Quantitative bone scintigraphy in evaluating treatment of renal osteodystrophy. Neth J Med 26:125–129
De Graaf P, Pauwels EKJ, Vos PH, Schicht IM, te Velde J, de Graeff J (1984) Observation on computed quantitative bone scintigraphy in renal osteodystrophy. Eur J Nucl Med 9:419–425
Fogelman I, Bessent RG, Turner JG, Citrin DL, Boyle IT, Greig WR (1978) The use of whole body retention of 99mTc-diphosphonate in the diagnosis of metabolic bone disease. J Nucl Med 19:270–275
Fogelman I, Bessent RG, Gordon D (1981) A critical assessment of bone scan quantitation (bone of soft tissue ratios) in the diagnosis of metabolic bone disease. Eur J Nucl Med 6:93–97
Kida T, Higuchi Y, Kato K (1982) Correlation between the extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase levels in serum with Eiken PAP-RIA kit. Proc. Third World Congress Nuclear Medicine, Paris, pp 858–861
Kida T, Higuchi Y (1983) Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase in serum with Eiken PAP RIA kit. Oncology 40:346–350
Langhammer H, Sinterman R, Kempken K, Hör G, Pabst HW, Fendl M (1977) Kameraszintigraphische Metastasendiagnostik am Skelettsystem beim Prostatacarzinom. Med Klin 72:942–951
Morley TR, Short MD, Dowsett DJ (1978) Femoral head activity in Perthes' disease: Clinical evaluation of a quantitative technique for estimating tracer uptake. J Nucl Med 19:884–890
Murray JPC (1974) Clinical uses of bone scanning. Proc First Congr Nucl Med, Tokyo Kyoto, pp 208–220
Pfeifer JP, Büll U, Pfeifer H (1979) Quantitative assessment of 99mTc-MDP scans in investigation of diffuse alterations in bone. Eur J Nucl Med 4:407–412
Silberstein EB, Saenger EL, Tofe AJ, Alexander GW, Park HM (1973) Imaging of bone metastases with 99mTc-Sn-EHDP (diphosphonate), 18F, and skeletal radiography. Radiology 107:551–555
Subramanian G, McAfee JG, Blair RJ, Kallfelz Fa, Thomas FD (1975) Technetium-99m-methylene diphosphonate a superior agent for skeletal imaging: Comparison with other technetium complex. J Nucl Med 16:744–755
Tofe AJ, Francis MD, Harvey WJ (1975) Correlation of neoplasms with incidence and localization of skeletal metastases: an analysis of 1355 diphosphonate bone scans. J Nucl Med 16:986–989
Waxman AD, Ducker S, McKee D, Slemsen JK, Siger FR (1977) Evaluation of 99mTc-diphosphonate kinetics and bone scan in patient with Paget's disease before and after calcitonin treatment. Radiology 125:761–764
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kida, T., Narita, S. A trial of semiquantitative analysis of whole body bone scintigraphy in renal osteodystrophy. Eur J Nucl Med 13, 36–40 (1987). https://doi.org/10.1007/BF00252644
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00252644